Francesco Gargano, MD
Plastic and Reconstructive Surgery · New York, NYNPI 1831359421
Payments from drug & device makers
What this record shows
8 manufacturers reported payments, led by Suvon Surgical LLC at 55.8% of the total. Reporting peaked in 2022 at $1,504 and has fallen 89.8% since, to $154 in 2024.
Across 12 payments — averaging $179.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Suvon Surgical LLC$1K
- Kerecis Limited$324
- Merz North America, Inc.$291
- Axogen$154
- Derma Sciences, Inc.$122
- Misonix Inc$34
- plus $27 from 2 others
What the payments were for
- Food & beverage$95244%
- Education$1,20056%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Suvon Surgical LLC | 1 | $1,200 |
| Kerecis Limited | 2 | $324 |
| Merz North America, Inc. | 3 | $291 |
| Axogen | 1 | $154 |
| Derma Sciences, Inc. | 1 | $122 |
| Misonix Inc | 2 | $34 |
| Smith+Nephew | 1 | $15 |
| Mentor Worldwide LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 Wound$324
- Kerecis Omega3 Surgibind$164
- Kerecis Omega3 GraftGuide$164
- Kerecis Omega3 SurgiClose$164
- AVANCE NERVE GRAFT$154
- AxoGuard Nerve Connector$154
- AxoGuard Nerve Protector$154
- AXOGUARD HA+ NERVE PROTECTOR$154
- AxoGuard Nerve Cap$154
- AMNIOEXCEL$122
- TCC-EZ$122
- PRIMATRIX$122
- IDRT$122
- OMNIGRAFT$122
How this compares
$2,152 in reported general payments places this provider in the 55th percentile of 219 plastic and reconstructive surgery providers in New York.
See all plastic and reconstructive surgery providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $83 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in New York
- Robert GrantNew York$207K
- Christine RohdeNew York$180K
- Steven LevineNew York$108K
- Theodore DiktabanNew York$83K
- Lawrence BassNew York$37K
- Nicholas BastidasNew York$27K
- Philip MillerNew York$24K
- Joseph DisaNew York$21K
- Graham SchwarzNew York$16K
- Evan MatrosNew York$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.